covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunoglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vacciner - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
omeprazol "medical valley" 10 mg enterokapsler, hårde
medical valley invest ab - omeprazol - enterokapsler, hårde - 10 mg
duloxetine "medical valley" 60 mg enterokapsler, hårde
medical valley invest ab - duloxetinhydrochlorid - enterokapsler, hårde - 60 mg
omeprazol "medical valley" 20 mg enterokapsler, hårde
medical valley invest ab - omeprazol - enterokapsler, hårde - 20 mg
omeprazol "medical valley" 40 mg enterokapsler, hårde
medical valley invest ab - omeprazol - enterokapsler, hårde - 40 mg
quetiapin "medical valley" 150 mg depottabletter
medical valley invest ab - quetiapin fumarat - depottabletter - 150 mg
quetiapin "medical valley" 200 mg depottabletter
medical valley invest ab - quetiapin fumarat - depottabletter - 200 mg
quetiapin "medical valley" 300 mg depottabletter
medical valley invest ab - quetiapin fumarat - depottabletter - 300 mg